ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Asthma Preventive Market Insights, Forecast to 2030
Published Date: December 2024
|
Report Code: QYRE-Auto-34J7209
Home | Market Reports | Health| Health Conditions| Respiratory Conditions
Global Asthma Preventive Market Insights Forecast to 2028
BUY CHAPTERS

Global Asthma Preventive Market Insights, Forecast to 2030

Code: QYRE-Auto-34J7209
Report
December 2024
Pages:114
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Pfizer Inc
Abbot
Novartis
Roche
GSK
Merck
Astrazeneca plc
Biotest
Boehringer Ingelheim
Chiesi
Sumitomo Dainippon Pharma
Amgen Inc

Asthma Preventive Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Asthma Preventive Market

Asthma Preventive Market

Asthma prophylaxis must be taken over a period of time to be effective. These drugs, however, are not suitable for the onset of the disease.
The global Asthma Preventive market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Covers:
This report presents an overview of global market for Asthma Preventive, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Asthma Preventive, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Asthma Preventive, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Asthma Preventive sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Asthma Preventive market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type, and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Asthma Preventive sales, projected growth trends, production technology, application and end-user industry.
Market Segmentation

Scope of Asthma Preventive Market Report

Report Metric Details
Report Name Asthma Preventive Market
CAGR 5%
Segment by Type
Segment by Application
  • Children
  • Adult
Segment by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Novartis, Roche, GSK, Merck, Astrazeneca, Biotest AG, Boehringer Ingelheim, Chiesi, Sumitomo Dainippon Pharma, Amgen
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Sales (consumption), revenue of Asthma Preventive in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 3: Detailed analysis of Asthma Preventive manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: North America (US & Canada) by Type, by Application and by country, sales, and revenue for each segment.
  • Chapter 7: Europe by Type, by Application and by country, sales, and revenue for each segment.
  • Chapter 8: China by Type, and by Application, sales, and revenue for each segment.
  • Chapter 9: Asia (excluding China) by Type, by Application and by region, sales, and revenue for each segment.
  • Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, sales, and revenue for each segment.
  • Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Asthma Preventive sales, revenue, price, gross margin, and recent development, etc.
  • Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
  • Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 14: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Asthma Preventive Market report?

Ans: The main players in the Asthma Preventive Market are Novartis, Roche, GSK, Merck, Astrazeneca, Biotest AG, Boehringer Ingelheim, Chiesi, Sumitomo Dainippon Pharma, Amgen

What are the Application segmentation covered in the Asthma Preventive Market report?

Ans: The Applications covered in the Asthma Preventive Market report are Children, Adult

What are the Type segmentation covered in the Asthma Preventive Market report?

Ans: The Types covered in the Asthma Preventive Market report are Sodium Cromolyn, Prednisolone

Recommended Reports

Respiratory Drugs

Allergy Treatments

Sleep and CNS Care

1 Study Coverage
1.1 Asthma Preventive Product Introduction
1.2 Market by Type
1.2.1 Global Asthma Preventive Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 Sodium Cromolyn
1.2.3 Prednisolone
1.3 Market by Application
1.3.1 Global Asthma Preventive Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 Children
1.3.3 Adult
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Asthma Preventive Sales Estimates and Forecasts 2019-2030
2.2 Global Asthma Preventive Revenue by Region
2.2.1 Global Asthma Preventive Revenue by Region: 2019 VS 2023 VS 2030
2.2.2 Global Asthma Preventive Revenue by Region (2019-2024)
2.2.3 Global Asthma Preventive Revenue by Region (2025-2030)
2.2.4 Global Asthma Preventive Revenue Market Share by Region (2019-2030)
2.3 Global Asthma Preventive Sales Estimates and Forecasts 2019-2030
2.4 Global Asthma Preventive Sales by Region
2.4.1 Global Asthma Preventive Sales by Region: 2019 VS 2023 VS 2030
2.4.2 Global Asthma Preventive Sales by Region (2019-2024)
2.4.3 Global Asthma Preventive Sales by Region (2025-2030)
2.4.4 Global Asthma Preventive Sales Market Share by Region (2019-2030)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global Asthma Preventive Sales by Manufacturers
3.1.1 Global Asthma Preventive Sales by Manufacturers (2019-2024)
3.1.2 Global Asthma Preventive Sales Market Share by Manufacturers (2019-2024)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Asthma Preventive in 2023
3.2 Global Asthma Preventive Revenue by Manufacturers
3.2.1 Global Asthma Preventive Revenue by Manufacturers (2019-2024)
3.2.2 Global Asthma Preventive Revenue Market Share by Manufacturers (2019-2024)
3.2.3 Global Top 10 and Top 5 Companies by Asthma Preventive Revenue in 2023
3.3 Global Key Players of Asthma Preventive, Industry Ranking, 2022 VS 2023 VS 2024
3.4 Global Asthma Preventive Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Asthma Preventive Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Asthma Preventive, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Asthma Preventive, Product Offered and Application
3.8 Global Key Manufacturers of Asthma Preventive, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Asthma Preventive Sales by Type
4.1.1 Global Asthma Preventive Historical Sales by Type (2019-2024)
4.1.2 Global Asthma Preventive Forecasted Sales by Type (2025-2030)
4.1.3 Global Asthma Preventive Sales Market Share by Type (2019-2030)
4.2 Global Asthma Preventive Revenue by Type
4.2.1 Global Asthma Preventive Historical Revenue by Type (2019-2024)
4.2.2 Global Asthma Preventive Forecasted Revenue by Type (2025-2030)
4.2.3 Global Asthma Preventive Revenue Market Share by Type (2019-2030)
4.3 Global Asthma Preventive Price by Type
4.3.1 Global Asthma Preventive Price by Type (2019-2024)
4.3.2 Global Asthma Preventive Price Forecast by Type (2025-2030)
5 Market Size by Application
5.1 Global Asthma Preventive Sales by Application
5.1.1 Global Asthma Preventive Historical Sales by Application (2019-2024)
5.1.2 Global Asthma Preventive Forecasted Sales by Application (2025-2030)
5.1.3 Global Asthma Preventive Sales Market Share by Application (2019-2030)
5.2 Global Asthma Preventive Revenue by Application
5.2.1 Global Asthma Preventive Historical Revenue by Application (2019-2024)
5.2.2 Global Asthma Preventive Forecasted Revenue by Application (2025-2030)
5.2.3 Global Asthma Preventive Revenue Market Share by Application (2019-2030)
5.3 Global Asthma Preventive Price by Application
5.3.1 Global Asthma Preventive Price by Application (2019-2024)
5.3.2 Global Asthma Preventive Price Forecast by Application (2025-2030)
6 US & Canada
6.1 US & Canada Asthma Preventive Market Size by Type
6.1.1 US & Canada Asthma Preventive Sales by Type (2019-2030)
6.1.2 US & Canada Asthma Preventive Revenue by Type (2019-2030)
6.2 US & Canada Asthma Preventive Market Size by Application
6.2.1 US & Canada Asthma Preventive Sales by Application (2019-2030)
6.2.2 US & Canada Asthma Preventive Revenue by Application (2019-2030)
6.3 US & Canada Asthma Preventive Market Size by Country
6.3.1 US & Canada Asthma Preventive Revenue by Country: 2019 VS 2023 VS 2030
6.3.2 US & Canada Asthma Preventive Sales by Country (2019-2030)
6.3.3 US & Canada Asthma Preventive Revenue by Country (2019-2030)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Asthma Preventive Market Size by Type
7.1.1 Europe Asthma Preventive Sales by Type (2019-2030)
7.1.2 Europe Asthma Preventive Revenue by Type (2019-2030)
7.2 Europe Asthma Preventive Market Size by Application
7.2.1 Europe Asthma Preventive Sales by Application (2019-2030)
7.2.2 Europe Asthma Preventive Revenue by Application (2019-2030)
7.3 Europe Asthma Preventive Market Size by Country
7.3.1 Europe Asthma Preventive Revenue by Country: 2019 VS 2023 VS 2030
7.3.2 Europe Asthma Preventive Sales by Country (2019-2030)
7.3.3 Europe Asthma Preventive Revenue by Country (2019-2030)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Asthma Preventive Market Size
8.1.1 China Asthma Preventive Sales (2019-2030)
8.1.2 China Asthma Preventive Revenue (2019-2030)
8.2 China Asthma Preventive Market Size by Application
8.2.1 China Asthma Preventive Sales by Application (2019-2030)
8.2.2 China Asthma Preventive Revenue by Application (2019-2030)
9 Asia (excluding China)
9.1 Asia Asthma Preventive Market Size by Type
9.1.1 Asia Asthma Preventive Sales by Type (2019-2030)
9.1.2 Asia Asthma Preventive Revenue by Type (2019-2030)
9.2 Asia Asthma Preventive Market Size by Application
9.2.1 Asia Asthma Preventive Sales by Application (2019-2030)
9.2.2 Asia Asthma Preventive Revenue by Application (2019-2030)
9.3 Asia Asthma Preventive Sales by Region
9.3.1 Asia Asthma Preventive Revenue by Region: 2019 VS 2023 VS 2030
9.3.2 Asia Asthma Preventive Revenue by Region (2019-2030)
9.3.3 Asia Asthma Preventive Sales by Region (2019-2030)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Asthma Preventive Market Size by Type
10.1.1 Middle East, Africa and Latin America Asthma Preventive Sales by Type (2019-2030)
10.1.2 Middle East, Africa and Latin America Asthma Preventive Revenue by Type (2019-2030)
10.2 Middle East, Africa and Latin America Asthma Preventive Market Size by Application
10.2.1 Middle East, Africa and Latin America Asthma Preventive Sales by Application (2019-2030)
10.2.2 Middle East, Africa and Latin America Asthma Preventive Revenue by Application (2019-2030)
10.3 Middle East, Africa and Latin America Asthma Preventive Sales by Country
10.3.1 Middle East, Africa and Latin America Asthma Preventive Revenue by Country: 2019 VS 2023 VS 2030
10.3.2 Middle East, Africa and Latin America Asthma Preventive Revenue by Country (2019-2030)
10.3.3 Middle East, Africa and Latin America Asthma Preventive Sales by Country (2019-2030)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 Pfizer
11.1.1 Pfizer Company Information
11.1.2 Pfizer Overview
11.1.3 Pfizer Asthma Preventive Sales, Price, Revenue and Gross Margin (2019-2024)
11.1.4 Pfizer Asthma Preventive Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Pfizer Recent Developments
11.2 Abbot
11.2.1 Abbot Company Information
11.2.2 Abbot Overview
11.2.3 Abbot Asthma Preventive Sales, Price, Revenue and Gross Margin (2019-2024)
11.2.4 Abbot Asthma Preventive Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Abbot Recent Developments
11.3 Novartis
11.3.1 Novartis Company Information
11.3.2 Novartis Overview
11.3.3 Novartis Asthma Preventive Sales, Price, Revenue and Gross Margin (2019-2024)
11.3.4 Novartis Asthma Preventive Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Novartis Recent Developments
11.4 Roche
11.4.1 Roche Company Information
11.4.2 Roche Overview
11.4.3 Roche Asthma Preventive Sales, Price, Revenue and Gross Margin (2019-2024)
11.4.4 Roche Asthma Preventive Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Roche Recent Developments
11.5 GSK
11.5.1 GSK Company Information
11.5.2 GSK Overview
11.5.3 GSK Asthma Preventive Sales, Price, Revenue and Gross Margin (2019-2024)
11.5.4 GSK Asthma Preventive Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 GSK Recent Developments
11.6 Merck
11.6.1 Merck Company Information
11.6.2 Merck Overview
11.6.3 Merck Asthma Preventive Sales, Price, Revenue and Gross Margin (2019-2024)
11.6.4 Merck Asthma Preventive Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Merck Recent Developments
11.7 Astrazeneca
11.7.1 Astrazeneca Company Information
11.7.2 Astrazeneca Overview
11.7.3 Astrazeneca Asthma Preventive Sales, Price, Revenue and Gross Margin (2019-2024)
11.7.4 Astrazeneca Asthma Preventive Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Astrazeneca Recent Developments
11.8 Biotest AG
11.8.1 Biotest AG Company Information
11.8.2 Biotest AG Overview
11.8.3 Biotest AG Asthma Preventive Sales, Price, Revenue and Gross Margin (2019-2024)
11.8.4 Biotest AG Asthma Preventive Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Biotest AG Recent Developments
11.9 Boehringer Ingelheim
11.9.1 Boehringer Ingelheim Company Information
11.9.2 Boehringer Ingelheim Overview
11.9.3 Boehringer Ingelheim Asthma Preventive Sales, Price, Revenue and Gross Margin (2019-2024)
11.9.4 Boehringer Ingelheim Asthma Preventive Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Boehringer Ingelheim Recent Developments
11.10 Chiesi
11.10.1 Chiesi Company Information
11.10.2 Chiesi Overview
11.10.3 Chiesi Asthma Preventive Sales, Price, Revenue and Gross Margin (2019-2024)
11.10.4 Chiesi Asthma Preventive Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Chiesi Recent Developments
11.11 Sumitomo Dainippon Pharma
11.11.1 Sumitomo Dainippon Pharma Company Information
11.11.2 Sumitomo Dainippon Pharma Overview
11.11.3 Sumitomo Dainippon Pharma Asthma Preventive Sales, Price, Revenue and Gross Margin (2019-2024)
11.11.4 Sumitomo Dainippon Pharma Asthma Preventive Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Sumitomo Dainippon Pharma Recent Developments
11.12 Amgen
11.12.1 Amgen Company Information
11.12.2 Amgen Overview
11.12.3 Amgen Asthma Preventive Sales, Price, Revenue and Gross Margin (2019-2024)
11.12.4 Amgen Asthma Preventive Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 Amgen Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Asthma Preventive Industry Chain Analysis
12.2 Asthma Preventive Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Asthma Preventive Production Mode & Process
12.4 Asthma Preventive Sales and Marketing
12.4.1 Asthma Preventive Sales Channels
12.4.2 Asthma Preventive Distributors
12.5 Asthma Preventive Customers
13 Market Dynamics
13.1 Asthma Preventive Industry Trends
13.2 Asthma Preventive Market Drivers
13.3 Asthma Preventive Market Challenges
13.4 Asthma Preventive Market Restraints
14 Key Findings in The Global Asthma Preventive Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
FEATURED COMPANIES
Pfizer Inc
Abbot
Novartis
Roche
GSK
Merck
Astrazeneca plc
Biotest
Boehringer Ingelheim
Chiesi
Sumitomo Dainippon Pharma
Amgen Inc
List of Tables
    Table 1. Global Asthma Preventive Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
    Table 2. Major Manufacturers of Sodium Cromolyn
    Table 3. Major Manufacturers of Prednisolone
    Table 4. Global Asthma Preventive Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
    Table 5. Global Asthma Preventive Revenue Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 6. Global Asthma Preventive Revenue by Region (2019-2024) & (US$ Million)
    Table 7. Global Asthma Preventive Revenue by Region (2025-2030) & (US$ Million)
    Table 8. Global Asthma Preventive Revenue Market Share by Region (2019-2024)
    Table 9. Global Asthma Preventive Revenue Market Share by Region (2025-2030)
    Table 10. Global Asthma Preventive Sales Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 11. Global Asthma Preventive Sales by Region (2019-2024) & (K Units)
    Table 12. Global Asthma Preventive Sales by Region (2025-2030) & (K Units)
    Table 13. Global Asthma Preventive Sales Market Share by Region (2019-2024)
    Table 14. Global Asthma Preventive Sales Market Share by Region (2025-2030)
    Table 15. Global Asthma Preventive Sales by Manufacturers (2019-2024) & (K Units)
    Table 16. Global Asthma Preventive Sales Share by Manufacturers (2019-2024)
    Table 17. Global Asthma Preventive Revenue by Manufacturers (2019-2024) & (US$ Million)
    Table 18. Global Asthma Preventive Revenue Share by Manufacturers (2019-2024)
    Table 19. Global Key Players of Asthma Preventive, Industry Ranking, 2022 VS 2023 VS 2024
    Table 20. Asthma Preventive Price by Manufacturers 2019-2024 (USD/Unit)
    Table 21. Global Asthma Preventive Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 22. Global Asthma Preventive by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Asthma Preventive as of 2023)
    Table 23. Global Key Manufacturers of Asthma Preventive, Manufacturing Base Distribution and Headquarters
    Table 24. Global Key Manufacturers of Asthma Preventive, Product Offered and Application
    Table 25. Global Key Manufacturers of Asthma Preventive, Date of Enter into This Industry
    Table 26. Mergers & Acquisitions, Expansion Plans
    Table 27. Global Asthma Preventive Sales by Type (2019-2024) & (K Units)
    Table 28. Global Asthma Preventive Sales by Type (2025-2030) & (K Units)
    Table 29. Global Asthma Preventive Sales Share by Type (2019-2024)
    Table 30. Global Asthma Preventive Sales Share by Type (2025-2030)
    Table 31. Global Asthma Preventive Revenue by Type (2019-2024) & (US$ Million)
    Table 32. Global Asthma Preventive Revenue by Type (2025-2030) & (US$ Million)
    Table 33. Global Asthma Preventive Revenue Share by Type (2019-2024)
    Table 34. Global Asthma Preventive Revenue Share by Type (2025-2030)
    Table 35. Asthma Preventive Price by Type (2019-2024) & (USD/Unit)
    Table 36. Global Asthma Preventive Price Forecast by Type (2025-2030) & (USD/Unit)
    Table 37. Global Asthma Preventive Sales by Application (2019-2024) & (K Units)
    Table 38. Global Asthma Preventive Sales by Application (2025-2030) & (K Units)
    Table 39. Global Asthma Preventive Sales Share by Application (2019-2024)
    Table 40. Global Asthma Preventive Sales Share by Application (2025-2030)
    Table 41. Global Asthma Preventive Revenue by Application (2019-2024) & (US$ Million)
    Table 42. Global Asthma Preventive Revenue by Application (2025-2030) & (US$ Million)
    Table 43. Global Asthma Preventive Revenue Share by Application (2019-2024)
    Table 44. Global Asthma Preventive Revenue Share by Application (2025-2030)
    Table 45. Asthma Preventive Price by Application (2019-2024) & (USD/Unit)
    Table 46. Global Asthma Preventive Price Forecast by Application (2025-2030) & (USD/Unit)
    Table 47. US & Canada Asthma Preventive Sales by Type (2019-2024) & (K Units)
    Table 48. US & Canada Asthma Preventive Sales by Type (2025-2030) & (K Units)
    Table 49. US & Canada Asthma Preventive Revenue by Type (2019-2024) & (US$ Million)
    Table 50. US & Canada Asthma Preventive Revenue by Type (2025-2030) & (US$ Million)
    Table 51. US & Canada Asthma Preventive Sales by Application (2019-2024) & (K Units)
    Table 52. US & Canada Asthma Preventive Sales by Application (2025-2030) & (K Units)
    Table 53. US & Canada Asthma Preventive Revenue by Application (2019-2024) & (US$ Million)
    Table 54. US & Canada Asthma Preventive Revenue by Application (2025-2030) & (US$ Million)
    Table 55. US & Canada Asthma Preventive Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 56. US & Canada Asthma Preventive Revenue by Country (2019-2024) & (US$ Million)
    Table 57. US & Canada Asthma Preventive Revenue by Country (2025-2030) & (US$ Million)
    Table 58. US & Canada Asthma Preventive Sales by Country (2019-2024) & (K Units)
    Table 59. US & Canada Asthma Preventive Sales by Country (2025-2030) & (K Units)
    Table 60. Europe Asthma Preventive Sales by Type (2019-2024) & (K Units)
    Table 61. Europe Asthma Preventive Sales by Type (2025-2030) & (K Units)
    Table 62. Europe Asthma Preventive Revenue by Type (2019-2024) & (US$ Million)
    Table 63. Europe Asthma Preventive Revenue by Type (2025-2030) & (US$ Million)
    Table 64. Europe Asthma Preventive Sales by Application (2019-2024) & (K Units)
    Table 65. Europe Asthma Preventive Sales by Application (2025-2030) & (K Units)
    Table 66. Europe Asthma Preventive Revenue by Application (2019-2024) & (US$ Million)
    Table 67. Europe Asthma Preventive Revenue by Application (2025-2030) & (US$ Million)
    Table 68. Europe Asthma Preventive Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 69. Europe Asthma Preventive Revenue by Country (2019-2024) & (US$ Million)
    Table 70. Europe Asthma Preventive Revenue by Country (2025-2030) & (US$ Million)
    Table 71. Europe Asthma Preventive Sales by Country (2019-2024) & (K Units)
    Table 72. Europe Asthma Preventive Sales by Country (2025-2030) & (K Units)
    Table 73. China Asthma Preventive Sales by Type (2019-2024) & (K Units)
    Table 74. China Asthma Preventive Sales by Type (2025-2030) & (K Units)
    Table 75. China Asthma Preventive Revenue by Type (2019-2024) & (US$ Million)
    Table 76. China Asthma Preventive Revenue by Type (2025-2030) & (US$ Million)
    Table 77. China Asthma Preventive Sales by Application (2019-2024) & (K Units)
    Table 78. China Asthma Preventive Sales by Application (2025-2030) & (K Units)
    Table 79. China Asthma Preventive Revenue by Application (2019-2024) & (US$ Million)
    Table 80. China Asthma Preventive Revenue by Application (2025-2030) & (US$ Million)
    Table 81. Asia Asthma Preventive Sales by Type (2019-2024) & (K Units)
    Table 82. Asia Asthma Preventive Sales by Type (2025-2030) & (K Units)
    Table 83. Asia Asthma Preventive Revenue by Type (2019-2024) & (US$ Million)
    Table 84. Asia Asthma Preventive Revenue by Type (2025-2030) & (US$ Million)
    Table 85. Asia Asthma Preventive Sales by Application (2019-2024) & (K Units)
    Table 86. Asia Asthma Preventive Sales by Application (2025-2030) & (K Units)
    Table 87. Asia Asthma Preventive Revenue by Application (2019-2024) & (US$ Million)
    Table 88. Asia Asthma Preventive Revenue by Application (2025-2030) & (US$ Million)
    Table 89. Asia Asthma Preventive Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 90. Asia Asthma Preventive Revenue by Region (2019-2024) & (US$ Million)
    Table 91. Asia Asthma Preventive Revenue by Region (2025-2030) & (US$ Million)
    Table 92. Asia Asthma Preventive Sales by Region (2019-2024) & (K Units)
    Table 93. Asia Asthma Preventive Sales by Region (2025-2030) & (K Units)
    Table 94. Middle East, Africa and Latin America Asthma Preventive Sales by Type (2019-2024) & (K Units)
    Table 95. Middle East, Africa and Latin America Asthma Preventive Sales by Type (2025-2030) & (K Units)
    Table 96. Middle East, Africa and Latin America Asthma Preventive Revenue by Type (2019-2024) & (US$ Million)
    Table 97. Middle East, Africa and Latin America Asthma Preventive Revenue by Type (2025-2030) & (US$ Million)
    Table 98. Middle East, Africa and Latin America Asthma Preventive Sales by Application (2019-2024) & (K Units)
    Table 99. Middle East, Africa and Latin America Asthma Preventive Sales by Application (2025-2030) & (K Units)
    Table 100. Middle East, Africa and Latin America Asthma Preventive Revenue by Application (2019-2024) & (US$ Million)
    Table 101. Middle East, Africa and Latin America Asthma Preventive Revenue by Application (2025-2030) & (US$ Million)
    Table 102. Middle East, Africa and Latin America Asthma Preventive Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 103. Middle East, Africa and Latin America Asthma Preventive Revenue by Country (2019-2024) & (US$ Million)
    Table 104. Middle East, Africa and Latin America Asthma Preventive Revenue by Country (2025-2030) & (US$ Million)
    Table 105. Middle East, Africa and Latin America Asthma Preventive Sales by Country (2019-2024) & (K Units)
    Table 106. Middle East, Africa and Latin America Asthma Preventive Sales by Country (2025-2030) & (K Units)
    Table 107. Pfizer Company Information
    Table 108. Pfizer Description and Major Businesses
    Table 109. Pfizer Asthma Preventive Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 110. Pfizer Asthma Preventive Product Model Numbers, Pictures, Descriptions and Specifications
    Table 111. Pfizer Recent Developments
    Table 112. Abbot Company Information
    Table 113. Abbot Description and Major Businesses
    Table 114. Abbot Asthma Preventive Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 115. Abbot Asthma Preventive Product Model Numbers, Pictures, Descriptions and Specifications
    Table 116. Abbot Recent Developments
    Table 117. Novartis Company Information
    Table 118. Novartis Description and Major Businesses
    Table 119. Novartis Asthma Preventive Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 120. Novartis Asthma Preventive Product Model Numbers, Pictures, Descriptions and Specifications
    Table 121. Novartis Recent Developments
    Table 122. Roche Company Information
    Table 123. Roche Description and Major Businesses
    Table 124. Roche Asthma Preventive Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 125. Roche Asthma Preventive Product Model Numbers, Pictures, Descriptions and Specifications
    Table 126. Roche Recent Developments
    Table 127. GSK Company Information
    Table 128. GSK Description and Major Businesses
    Table 129. GSK Asthma Preventive Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 130. GSK Asthma Preventive Product Model Numbers, Pictures, Descriptions and Specifications
    Table 131. GSK Recent Developments
    Table 132. Merck Company Information
    Table 133. Merck Description and Major Businesses
    Table 134. Merck Asthma Preventive Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 135. Merck Asthma Preventive Product Model Numbers, Pictures, Descriptions and Specifications
    Table 136. Merck Recent Developments
    Table 137. Astrazeneca Company Information
    Table 138. Astrazeneca Description and Major Businesses
    Table 139. Astrazeneca Asthma Preventive Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 140. Astrazeneca Asthma Preventive Product Model Numbers, Pictures, Descriptions and Specifications
    Table 141. Astrazeneca Recent Developments
    Table 142. Biotest AG Company Information
    Table 143. Biotest AG Description and Major Businesses
    Table 144. Biotest AG Asthma Preventive Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 145. Biotest AG Asthma Preventive Product Model Numbers, Pictures, Descriptions and Specifications
    Table 146. Biotest AG Recent Developments
    Table 147. Boehringer Ingelheim Company Information
    Table 148. Boehringer Ingelheim Description and Major Businesses
    Table 149. Boehringer Ingelheim Asthma Preventive Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 150. Boehringer Ingelheim Asthma Preventive Product Model Numbers, Pictures, Descriptions and Specifications
    Table 151. Boehringer Ingelheim Recent Developments
    Table 152. Chiesi Company Information
    Table 153. Chiesi Description and Major Businesses
    Table 154. Chiesi Asthma Preventive Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 155. Chiesi Asthma Preventive Product Model Numbers, Pictures, Descriptions and Specifications
    Table 156. Chiesi Recent Developments
    Table 157. Sumitomo Dainippon Pharma Company Information
    Table 158. Sumitomo Dainippon Pharma Description and Major Businesses
    Table 159. Sumitomo Dainippon Pharma Asthma Preventive Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 160. Sumitomo Dainippon Pharma Asthma Preventive Product Model Numbers, Pictures, Descriptions and Specifications
    Table 161. Sumitomo Dainippon Pharma Recent Developments
    Table 162. Amgen Company Information
    Table 163. Amgen Description and Major Businesses
    Table 164. Amgen Asthma Preventive Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 165. Amgen Asthma Preventive Product Model Numbers, Pictures, Descriptions and Specifications
    Table 166. Amgen Recent Developments
    Table 167. Key Raw Materials Lists
    Table 168. Raw Materials Key Suppliers Lists
    Table 169. Asthma Preventive Distributors List
    Table 170. Asthma Preventive Customers List
    Table 171. Asthma Preventive Market Trends
    Table 172. Asthma Preventive Market Drivers
    Table 173. Asthma Preventive Market Challenges
    Table 174. Asthma Preventive Market Restraints
    Table 175. Research Programs/Design for This Report
    Table 176. Key Data Information from Secondary Sources
    Table 177. Key Data Information from Primary Sources
List of Figures
    Figure 1. Asthma Preventive Product Picture
    Figure 2. Global Asthma Preventive Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 3. Global Asthma Preventive Market Share by Type in 2023 & 2030
    Figure 4. Sodium Cromolyn Product Picture
    Figure 5. Prednisolone Product Picture
    Figure 6. Global Asthma Preventive Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 7. Global Asthma Preventive Market Share by Application in 2023 & 2030
    Figure 8. Children
    Figure 9. Adult
    Figure 10. Asthma Preventive Report Years Considered
    Figure 11. Global Asthma Preventive Revenue, (US$ Million), 2019 VS 2023 VS 2030
    Figure 12. Global Asthma Preventive Revenue 2019-2030 (US$ Million)
    Figure 13. Global Asthma Preventive Revenue Market Share by Region in Percentage: 2023 Versus 2030
    Figure 14. Global Asthma Preventive Revenue Market Share by Region (2019-2030)
    Figure 15. Global Asthma Preventive Sales 2019-2030 ((K Units)
    Figure 16. Global Asthma Preventive Sales Market Share by Region (2019-2030)
    Figure 17. US & Canada Asthma Preventive Sales YoY (2019-2030) & (K Units)
    Figure 18. US & Canada Asthma Preventive Revenue YoY (2019-2030) & (US$ Million)
    Figure 19. Europe Asthma Preventive Sales YoY (2019-2030) & (K Units)
    Figure 20. Europe Asthma Preventive Revenue YoY (2019-2030) & (US$ Million)
    Figure 21. China Asthma Preventive Sales YoY (2019-2030) & (K Units)
    Figure 22. China Asthma Preventive Revenue YoY (2019-2030) & (US$ Million)
    Figure 23. Asia (excluding China) Asthma Preventive Sales YoY (2019-2030) & (K Units)
    Figure 24. Asia (excluding China) Asthma Preventive Revenue YoY (2019-2030) & (US$ Million)
    Figure 25. Middle East, Africa and Latin America Asthma Preventive Sales YoY (2019-2030) & (K Units)
    Figure 26. Middle East, Africa and Latin America Asthma Preventive Revenue YoY (2019-2030) & (US$ Million)
    Figure 27. The Asthma Preventive Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2023
    Figure 28. The Top 5 and 10 Largest Manufacturers of Asthma Preventive in the World: Market Share by Asthma Preventive Revenue in 2023
    Figure 29. Global Asthma Preventive Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
    Figure 30. Global Asthma Preventive Sales Market Share by Type (2019-2030)
    Figure 31. Global Asthma Preventive Revenue Market Share by Type (2019-2030)
    Figure 32. Global Asthma Preventive Sales Market Share by Application (2019-2030)
    Figure 33. Global Asthma Preventive Revenue Market Share by Application (2019-2030)
    Figure 34. US & Canada Asthma Preventive Sales Market Share by Type (2019-2030)
    Figure 35. US & Canada Asthma Preventive Revenue Market Share by Type (2019-2030)
    Figure 36. US & Canada Asthma Preventive Sales Market Share by Application (2019-2030)
    Figure 37. US & Canada Asthma Preventive Revenue Market Share by Application (2019-2030)
    Figure 38. US & Canada Asthma Preventive Revenue Share by Country (2019-2030)
    Figure 39. US & Canada Asthma Preventive Sales Share by Country (2019-2030)
    Figure 40. U.S. Asthma Preventive Revenue (2019-2030) & (US$ Million)
    Figure 41. Canada Asthma Preventive Revenue (2019-2030) & (US$ Million)
    Figure 42. Europe Asthma Preventive Sales Market Share by Type (2019-2030)
    Figure 43. Europe Asthma Preventive Revenue Market Share by Type (2019-2030)
    Figure 44. Europe Asthma Preventive Sales Market Share by Application (2019-2030)
    Figure 45. Europe Asthma Preventive Revenue Market Share by Application (2019-2030)
    Figure 46. Europe Asthma Preventive Revenue Share by Country (2019-2030)
    Figure 47. Europe Asthma Preventive Sales Share by Country (2019-2030)
    Figure 48. Germany Asthma Preventive Revenue (2019-2030) & (US$ Million)
    Figure 49. France Asthma Preventive Revenue (2019-2030) & (US$ Million)
    Figure 50. U.K. Asthma Preventive Revenue (2019-2030) & (US$ Million)
    Figure 51. Italy Asthma Preventive Revenue (2019-2030) & (US$ Million)
    Figure 52. Russia Asthma Preventive Revenue (2019-2030) & (US$ Million)
    Figure 53. China Asthma Preventive Sales Market Share by Type (2019-2030)
    Figure 54. China Asthma Preventive Revenue Market Share by Type (2019-2030)
    Figure 55. China Asthma Preventive Sales Market Share by Application (2019-2030)
    Figure 56. China Asthma Preventive Revenue Market Share by Application (2019-2030)
    Figure 57. Asia Asthma Preventive Sales Market Share by Type (2019-2030)
    Figure 58. Asia Asthma Preventive Revenue Market Share by Type (2019-2030)
    Figure 59. Asia Asthma Preventive Sales Market Share by Application (2019-2030)
    Figure 60. Asia Asthma Preventive Revenue Market Share by Application (2019-2030)
    Figure 61. Asia Asthma Preventive Revenue Share by Region (2019-2030)
    Figure 62. Asia Asthma Preventive Sales Share by Region (2019-2030)
    Figure 63. Japan Asthma Preventive Revenue (2019-2030) & (US$ Million)
    Figure 64. South Korea Asthma Preventive Revenue (2019-2030) & (US$ Million)
    Figure 65. China Taiwan Asthma Preventive Revenue (2019-2030) & (US$ Million)
    Figure 66. Southeast Asia Asthma Preventive Revenue (2019-2030) & (US$ Million)
    Figure 67. India Asthma Preventive Revenue (2019-2030) & (US$ Million)
    Figure 68. Middle East, Africa and Latin America Asthma Preventive Sales Market Share by Type (2019-2030)
    Figure 69. Middle East, Africa and Latin America Asthma Preventive Revenue Market Share by Type (2019-2030)
    Figure 70. Middle East, Africa and Latin America Asthma Preventive Sales Market Share by Application (2019-2030)
    Figure 71. Middle East, Africa and Latin America Asthma Preventive Revenue Market Share by Application (2019-2030)
    Figure 72. Middle East, Africa and Latin America Asthma Preventive Revenue Share by Country (2019-2030)
    Figure 73. Middle East, Africa and Latin America Asthma Preventive Sales Share by Country (2019-2030)
    Figure 74. Brazil Asthma Preventive Revenue (2019-2030) & (US$ Million)
    Figure 75. Mexico Asthma Preventive Revenue (2019-2030) & (US$ Million)
    Figure 76. Turkey Asthma Preventive Revenue (2019-2030) & (US$ Million)
    Figure 77. Israel Asthma Preventive Revenue (2019-2030) & (US$ Million)
    Figure 78. GCC Countries Asthma Preventive Revenue (2019-2030) & (US$ Million)
    Figure 79. Asthma Preventive Value Chain
    Figure 80. Asthma Preventive Production Process
    Figure 81. Channels of Distribution
    Figure 82. Distributors Profiles
    Figure 83. Bottom-up and Top-down Approaches for This Report
    Figure 84. Data Triangulation
    Figure 85. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$4900

This license allows only one user to access the PDF.
Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Accenture

SIMILAR REPORTS

Global Preventer Asthma Inhaler Market Research Report 2024
Global Asthma Allergy Treatment Market Insights Forecast to 2030
Global Asthma Inhalers Market Research Report 2025
Global Asthma Treatment Devices Market Insights Forecast to 2030
Global Asthma Detector Market Research Report 2024
Global Asthma Medication Market Research Report 2025
Global Asthma COPD Combination Medication Market Insights Forecast to 2030
Global Asthma Therapeutics Market Research Report 2025
Global Asthma Therapeutic Drug Market Research Report 2024
Global Allergic Asthma Therapeutics Market Research Report 2025
Long Term Asthma Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Expectorants Market Insights Forecast to 2030
Quick relief Asthma Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Medicines for Eosinophilic Asthma Treatment Market Research Report 2025
Long term Asthma Control Medication Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Asthma Clinical Therapeutic Drug Market Research Report 2025
Severe Asthma Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Smart Inhaler for Asthma Market Research Report 2024
Global Inhalers Market Research Report 2024
Global Cough Suppressants Market Insights Forecast to 2030

RELATED REPORTS

Global Inhaled Treatment for Asthma and COPD Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-19Y19888
Tue Sep 09 00:00:00 UTC 2025

Add to Cart

Global Oxygen Inhaler Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-11D3386
Tue Sep 09 00:00:00 UTC 2025

Add to Cart

Global Chronic Obstructive Pulmonary Disorder (COPD) Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-26D2937
Mon Sep 08 00:00:00 UTC 2025

Add to Cart

Global Bronchiectasis Treatment Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-18E6080
Mon Sep 08 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions